Novel strategies targeting detrimental airway inflammation
1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Sacrificial redox modulation by a secreted bacterial effector molecule mitigates oxidative stress and inflammation in vivo
- Contribution to journal › Article
- 2024
-
Mark
Macrophage expressed tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis progression
- Contribution to journal › Article
-
Mark
A novel quinoline with airway relaxant effects and anti-inflammatory properties
- Contribution to journal › Article
- 2023
-
Mark
Small-molecule-mediated OGG1 inhibition attenuates pulmonary inflammation and lung fibrosis in a murine lung fibrosis model
- Contribution to journal › Article
-
Mark
"Hereditary angioedema is associated with an increased risk of venous thromboembolism" : reply
- Contribution to journal › Letter
-
Mark
Trends in Treatments With Disease-Specific and Interfering Drugs in Patients With Hereditary Angioedema in Sweden
- Contribution to journal › Article
-
Mark
Substrate-specific binding of 8-oxoguanine DNA glycosylase 1 (OGG1) reprograms mucosal adaptations to chronic airway injury
- Contribution to journal › Scientific review
-
Mark
Epigenetic control of type III interferon expression by 8-oxoguanine and its reader 8-oxoguanine DNA glycosylase1
- Contribution to journal › Article
-
Mark
High prevalence of interstitial lung abnormalities in middle-aged never-smokers
- Contribution to journal › Article
-
Mark
8-Oxoguanine targeted by 8-oxoguanine DNA glycosylase 1 (OGG1) is central to fibrogenic gene activation upon lung injury
- Contribution to journal › Article
